John F. Miller

发表

Formation and isolation of simple, stable, acyclic di- and tripeptide hemiacetals

A. Spaltenstein, John F. Miller, 1996 .

Hepatitis C replication inhibitors that target the viral NS4B protein.

D. J. Price, R. Hamatake, Z. Hong, 2014, Journal of medicinal chemistry.

Synthesis of HCV replicase inhibitors: base-catalyzed synthesis of protected α-hydrazino esters and selective aerobic oxidation with catalytic Pt/Bi/C for synthesis of imidazole-4,5-dicarbaldehyde.

D. E. Patterson, John F. Miller, M. Mitchell, 2013, The Journal of organic chemistry.

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.

M. Hanlon, E. Furfine, R. Xu, 2006, Bioorganic & medicinal chemistry letters.

Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains.

J. A. Ray, M. Hanlon, E. Furfine, 2004, Bioorganic & medicinal chemistry letters.

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals and against a Panel of Protease Inhibitor-Resistant HIV

M. Hanlon, E. Furfine, P. Yates, 2007, Antimicrobial Agents and Chemotherapy.

Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.

Michael Brieger, E. Furfine, R. Hazen, 2005, Bioorganic & medicinal chemistry letters.

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeﬁciency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals and against a Panel of Protease Inhibitor-Resistant HIV (cid:1)

E. Furfine, L. Boone, P. Yates, 2007 .

Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.

S. Jenkinson, K. Gudmundsson, A. Spaltenstein, 2010, Bioorganic & medicinal chemistry letters.

Ring closing metathesis in organic synthesis: Evolution of a high speed, solid phase method for the preparation of β-turn mimetics

John F. Miller, A. Piscopio, K. Koch, 1999 .

Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity.

S. Jenkinson, K. Gudmundsson, A. Spaltenstein, 2010, Bioorganic & medicinal chemistry letters.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

J. Lehmann, T. Willson, S. Kliewer, 1998, Journal of medicinal chemistry.

Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanism.

Ryan Lauchli, A. Mathis, John F. Miller, 2014, Journal of medicinal chemistry.

Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamides.

M. Hanlon, E. Furfine, A. Shu, 2004, Biochemistry.

Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.

E. Furfine, R. Hazen, David J. Reynolds, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and reactions of enantiomerically pure molybdenum .pi.-complexes of 2H-pyran. A general approach to the enantiospecific synthesis of cis-2,5-disubstituted-5,6-dihydro-2H-pyrans and cis-2,6-disubstituted tetrahydropyrans

John F. Miller, L. S. Liebeskind, S. Hansson, 1990 .

Discovery of next generation inhibitors of HIV protease.

W. Kazmierski, V. Samano, A. Spaltenstein, 2005, Current topics in medicinal chemistry.

Solid phase heterocyclic synthesis via ring closing metathesis: Traceless linking and cyclative cleavage through a carbon-carbon double bond☆

John F. Miller, A. Piscopio, K. Koch, 1997 .